(GEN) Gen Digital - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6687711084
Stock: Cybersecurity, Identity Protection, Privacy, Performance Management
Total Rating 24
Risk 63
Buy Signal -0.61
| Risk 5d forecast | |
|---|---|
| Volatility | 28.2% |
| Relative Tail Risk | -9.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.94 |
| Alpha | -45.38 |
| Character TTM | |
|---|---|
| Beta | 1.115 |
| Beta Downside | 0.888 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.17% |
| CAGR/Max DD | 0.29 |
EPS (Earnings per Share)
Revenue
Description: GEN Gen Digital March 04, 2026
Gen Digital Inc. (GEN) provides cybersecurity solutions to individuals, families, and small businesses. Its offerings include security, performance management, identity protection, and online privacy. This business model relies on recurring subscriptions for digital protection services.
The company markets its products under several brands, including Norton, Avast, LifeLock, and Avira. The cybersecurity sector is characterized by continuous threats and evolving defense mechanisms.
Formerly NortonLifeLock Inc., the company rebranded in November 2022. Gen Digital Inc. was founded in 1982 and is headquartered in Tempe, Arizona.
For more detailed financial and operational data, ValueRay offers comprehensive company profiles.
Headlines to watch out for
- Subscription renewals drive recurring revenue growth
- Cybersecurity threat landscape increases demand for protection
- Acquisition strategy expands product portfolio and market share
- Data privacy regulations impact product development and compliance costs
- Inflationary pressures affect consumer discretionary spending on subscriptions
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 603.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -4.29 > 1.0 |
| NWC/Revenue: -30.36% < 20% (prev -62.80%; Δ 32.44% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.54b > Net Income 603.0m |
| Net Debt (7.79b) to EBITDA (2.18b): 3.57 < 3 |
| Current Ratio: 0.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (622.0m) vs 12m ago -0.16% < -2% |
| Gross Margin: 77.68% > 18% (prev 0.80%; Δ 7.69k% > 0.5%) |
| Asset Turnover: 30.31% > 50% (prev 25.33%; Δ 4.97% > 0%) |
| Interest Coverage Ratio: 2.97 > 6 (EBITDA TTM 2.18b / Interest Expense TTM 574.0m) |
Altman Z'' 0.33
| A: -0.09 (Total Current Assets 1.25b - Total Current Liabilities 2.69b) / Total Assets 15.83b |
| B: 0.00 (Retained Earnings 32.0m / Total Assets 15.83b) |
| C: 0.11 (EBIT TTM 1.70b / Avg Total Assets 15.60b) |
| D: 0.17 (Book Value of Equity 2.33b / Total Liabilities 13.50b) |
| Altman-Z'' Score: 0.33 = B |
Beneish M -2.23
| DSRI: 1.81 (Receivables 361.0m/164.0m, Revenue 4.73b/3.89b) |
| GMI: 1.03 (GM 77.68% / 80.29%) |
| AQI: 1.01 (AQ_t 0.92 / AQ_t-1 0.91) |
| SGI: 1.21 (Revenue 4.73b / 3.89b) |
| TATA: -0.06 (NI 603.0m - CFO 1.54b) / TA 15.83b) |
| Beneish M-Score: -2.23 (Cap -4..+1) = BBB |
What is the price of GEN shares?
As of March 20, 2026, the stock is trading at USD 20.56 with a total of 6,856,278 shares traded.
Over the past week, the price has changed by -2.10%, over one month by -7.97%, over three months by -25.14% and over the past year by -24.94%.
Over the past week, the price has changed by -2.10%, over one month by -7.97%, over three months by -25.14% and over the past year by -24.94%.
Is GEN a buy, sell or hold?
Gen Digital has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy GEN.
- StrongBuy: 4
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.2 | 51.7% |
| Analysts Target Price | 31.2 | 51.7% |
GEN Fundamental Data Overview March 16, 2026
P/E Trailing = 21.3196
P/E Forward = 7.1582
P/S = 2.6981
P/B = 5.371
P/EG = 0.5185
Revenue TTM = 4.73b USD
EBIT TTM = 1.70b USD
EBITDA TTM = 2.18b USD
Long Term Debt = 8.17b USD (from longTermDebt, last quarter)
Short Term Debt = 240.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.79b USD (from netDebt column, last quarter)
Enterprise Value = 20.54b USD (12.75b + Debt 8.41b - CCE 619.0m)
Interest Coverage Ratio = 2.97 (Ebit TTM 1.70b / Interest Expense TTM 574.0m)
EV/FCF = 13.54x (Enterprise Value 20.54b / FCF TTM 1.52b)
FCF Yield = 7.38% (FCF TTM 1.52b / Enterprise Value 20.54b)
FCF Margin = 32.09% (FCF TTM 1.52b / Revenue TTM 4.73b)
Net Margin = 12.76% (Net Income TTM 603.0m / Revenue TTM 4.73b)
Gross Margin = 77.68% ((Revenue TTM 4.73b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 73.95% (prev 78.20%)
Tobins Q-Ratio = 1.30 (Enterprise Value 20.54b / Total Assets 15.83b)
Interest Expense / Debt = 1.63% (Interest Expense 137.0m / Debt 8.41b)
Taxrate = 37.86% (117.0m / 309.0m)
NOPAT = 1.06b (EBIT 1.70b * (1 - 37.86%))
Current Ratio = 0.47 (Total Current Assets 1.25b / Total Current Liabilities 2.69b)
Debt / Equity = 3.61 (Debt 8.41b / totalStockholderEquity, last quarter 2.33b)
Debt / EBITDA = 3.57 (Net Debt 7.79b / EBITDA 2.18b)
Debt / FCF = 5.13 (Net Debt 7.79b / FCF TTM 1.52b)
Total Stockholder Equity = 2.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.87% (Net Income 603.0m / Total Assets 15.83b)
RoE = 25.60% (Net Income TTM 603.0m / Total Stockholder Equity 2.36b)
RoCE = 16.18% (EBIT 1.70b / Capital Employed (Equity 2.36b + L.T.Debt 8.17b))
RoIC = 10.17% (NOPAT 1.06b / Invested Capital 10.40b)
WACC = 6.44% (E(12.75b)/V(21.16b) * Re(10.02%) + D(8.41b)/V(21.16b) * Rd(1.63%) * (1-Tc(0.38)))
Discount Rate = 10.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.80%
[DCF] Terminal Value 84.51% ; FCFF base≈1.76b ; Y1≈1.83b ; Y5≈2.07b
[DCF] Fair Price = 73.29 (EV 52.18b - Net Debt 7.79b = Equity 44.39b / Shares 605.7m; r=6.44% [WACC]; 5y FCF grow 3.71% → 2.90% )
EPS Correlation: 95.94 | EPS CAGR: 9.21% | SUE: 0.69 | # QB: 0
Revenue Correlation: 90.64 | Revenue CAGR: 15.77% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.68 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=7
EPS next Year (2027-03-31): EPS=2.87 | Chg7d=-0.002 | Chg30d=+0.012 | Revisions Net=+5 | Growth EPS=+12.7% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.3% (Discount Rate 10.0% - Earnings Yield 4.7%)
[Growth] Growth Spread = -4.3% (Analyst 1.0% - Implied 5.3%)
P/E Forward = 7.1582
P/S = 2.6981
P/B = 5.371
P/EG = 0.5185
Revenue TTM = 4.73b USD
EBIT TTM = 1.70b USD
EBITDA TTM = 2.18b USD
Long Term Debt = 8.17b USD (from longTermDebt, last quarter)
Short Term Debt = 240.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.79b USD (from netDebt column, last quarter)
Enterprise Value = 20.54b USD (12.75b + Debt 8.41b - CCE 619.0m)
Interest Coverage Ratio = 2.97 (Ebit TTM 1.70b / Interest Expense TTM 574.0m)
EV/FCF = 13.54x (Enterprise Value 20.54b / FCF TTM 1.52b)
FCF Yield = 7.38% (FCF TTM 1.52b / Enterprise Value 20.54b)
FCF Margin = 32.09% (FCF TTM 1.52b / Revenue TTM 4.73b)
Net Margin = 12.76% (Net Income TTM 603.0m / Revenue TTM 4.73b)
Gross Margin = 77.68% ((Revenue TTM 4.73b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 73.95% (prev 78.20%)
Tobins Q-Ratio = 1.30 (Enterprise Value 20.54b / Total Assets 15.83b)
Interest Expense / Debt = 1.63% (Interest Expense 137.0m / Debt 8.41b)
Taxrate = 37.86% (117.0m / 309.0m)
NOPAT = 1.06b (EBIT 1.70b * (1 - 37.86%))
Current Ratio = 0.47 (Total Current Assets 1.25b / Total Current Liabilities 2.69b)
Debt / Equity = 3.61 (Debt 8.41b / totalStockholderEquity, last quarter 2.33b)
Debt / EBITDA = 3.57 (Net Debt 7.79b / EBITDA 2.18b)
Debt / FCF = 5.13 (Net Debt 7.79b / FCF TTM 1.52b)
Total Stockholder Equity = 2.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.87% (Net Income 603.0m / Total Assets 15.83b)
RoE = 25.60% (Net Income TTM 603.0m / Total Stockholder Equity 2.36b)
RoCE = 16.18% (EBIT 1.70b / Capital Employed (Equity 2.36b + L.T.Debt 8.17b))
RoIC = 10.17% (NOPAT 1.06b / Invested Capital 10.40b)
WACC = 6.44% (E(12.75b)/V(21.16b) * Re(10.02%) + D(8.41b)/V(21.16b) * Rd(1.63%) * (1-Tc(0.38)))
Discount Rate = 10.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.80%
[DCF] Terminal Value 84.51% ; FCFF base≈1.76b ; Y1≈1.83b ; Y5≈2.07b
[DCF] Fair Price = 73.29 (EV 52.18b - Net Debt 7.79b = Equity 44.39b / Shares 605.7m; r=6.44% [WACC]; 5y FCF grow 3.71% → 2.90% )
EPS Correlation: 95.94 | EPS CAGR: 9.21% | SUE: 0.69 | # QB: 0
Revenue Correlation: 90.64 | Revenue CAGR: 15.77% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.68 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=7
EPS next Year (2027-03-31): EPS=2.87 | Chg7d=-0.002 | Chg30d=+0.012 | Revisions Net=+5 | Growth EPS=+12.7% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.3% (Discount Rate 10.0% - Earnings Yield 4.7%)
[Growth] Growth Spread = -4.3% (Analyst 1.0% - Implied 5.3%)